Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition
about
Genetic and epigenetic traits as biomarkers in colorectal cancerSNPs Array Karyotyping in Non-Hodgkin LymphomaA pan-cancer proteomic perspective on The Cancer Genome Atlas.Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysisIdentification of novel mutations by exome sequencing in African American colorectal cancer patientsSerpin B5 is a CEA-interacting biomarker for colorectal cancer.Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancerThe effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patientsDDA1 promotes stage IIB-IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling.Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing.Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer.Ultrasound imaging of splenomegaly as a proxy to monitor colon tumor development in Apc(min716/+) mice.Toxicogenomics and cancer susceptibility: advances with next-generation sequencing.Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen.Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients.MicroRNA-449a deficiency promotes colon carcinogenesis.Correlations between TBL1XR1 and recurrence of colorectal cancer.Early Assessment of Colorectal Cancer by Quantifying Circulating Tumor Cells in Peripheral Blood: ECT2 in Diagnosis of Colorectal Cancer.The pattern of epidermal growth factor receptor variation with disease progression and aggressiveness in colorectal cancer depends on tumor location.EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer.EphA2 signaling is impacted by carcinoembryonic antigen cell adhesion molecule 1-L expression in colorectal cancer liver metastasis in a cell context-dependent manner.Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patientsIdentification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer
P2860
Q27016019-297311A1-6C62-4D5A-A987-96F1EB55C4E0Q28085444-6557224D-34DD-4FF6-9F1B-36026769BE84Q33944976-F39698EE-988F-4F2D-9558-5B70BF4D5A3AQ34766411-C9F147E4-A32B-4B51-9828-19501AED69B8Q34977426-5750086C-4205-49E5-ADED-6406540B1993Q35013998-C367FDF3-633F-4A76-984F-6944AA823C2AQ35447606-6B70DD7E-949E-48A8-8DF8-8410964BCD34Q35668717-8E2EB50B-1514-48B6-A95F-362AEFEC0C49Q36156772-62BBDD77-262B-41B7-9C1B-EB798574383AQ36940977-723938D9-9060-4660-B74D-1995E6FBAD16Q37071863-1121872E-4A05-4D71-B4D9-EFF5C60BD0E6Q37190177-D3978D65-F734-46D0-B6BE-4EF535276126Q37236012-1AFB7FC5-C70C-4E04-8922-C46E5531D3D0Q37259562-E89CC080-C97B-4905-970D-3376948F6B89Q37321017-A9B996CB-8849-403D-AAA2-EFC4C6AE2D67Q38215923-B1E0F5F4-4670-4588-BB1D-F42BE8DA8EDBQ38943220-8E1AFB14-2E5B-4798-9100-B104BD719540Q39024684-5B509633-DE86-4555-8563-FF6DCD1F2AE9Q41627283-AC3F0F00-8903-4378-B317-824069557D17Q41779003-A40A3082-90D9-48F0-A139-CF96D1E321A7Q42198617-EF051FA2-0057-429D-98C6-92872AECB06CQ42225261-8DAF06F9-9DBF-439D-8713-7E567A2EFAE2Q42252801-E0435A01-C3F5-43A8-8E7F-F7F122B07092Q44070246-25AFD6D5-E4DD-4C18-B54B-959EDECF4099Q47158629-1AAA2F73-3BC1-481F-A2DA-41871947CBF2Q57191753-9F21BBA1-84C8-45F2-9F78-7B04D25D3780Q58051474-39EE4038-36B2-46DE-B9CC-680D154D9698
P2860
Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular profiling of colon t ...... erapeutics, and predisposition
@ast
Molecular profiling of colon t ...... erapeutics, and predisposition
@en
type
label
Molecular profiling of colon t ...... erapeutics, and predisposition
@ast
Molecular profiling of colon t ...... erapeutics, and predisposition
@en
prefLabel
Molecular profiling of colon t ...... erapeutics, and predisposition
@ast
Molecular profiling of colon t ...... erapeutics, and predisposition
@en
P2860
P1476
Molecular profiling of colon t ...... erapeutics, and predisposition
@en
P2093
Francis Barany
Manny D Bacolod
P2860
P2888
P304
P356
10.1245/S10434-011-1615-5
P577
2011-02-24T00:00:00Z
P5875
P6179
1007367092